rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Steve Miller

Chief Op. & Scientific Officer

Company insider

Files Form 4 as: Chief Op. & Scientific Officer, Catalyst Pharmaceutical.

In numbers

Trades disclosed
136
Buys
3
Sells
10
Bought
$253K
Sold
$13.2M
Companies
1
Companies where not an officer
0
First trade
1 Jan 2008
Last trade
15 Jul 2026
Last filed
17 Jul 2026

Companies traded

Where they are an officer
Catalyst PharmaceuticalOfficer · Biotechnology · last 15 Jul 20263 buys · 10 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
10Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 17 Jul 2026Catalyst PharmaceuticalBiotechnologySEC FORM 4 Code D$34.5M1,093,803 at $31.50filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—16,534 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—47,826 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—180,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—275,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—180,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—275,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—185,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—146,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—248,004 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—202,958 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—158,454 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—11,873 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—16,534 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticalsoption or derivativeSEC FORM 4 Code D—47,826 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—185,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—146,000 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—248,004 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—202,958 at $0.00filing
15 Jul 2026filed 17 Jul 2026Catalyst Pharmaceuticaloption or derivative · BiotechnologySEC FORM 4 Code D—158,454 at $0.00filing

News

Ladle Names Steve Miller EVP, Grocery Pricing Operationsprnewswire.com · 1 Oct 2026

1 headline in the last 90 days name Steve Miller; no company of theirs resolves to a name we track.

Sectors

Not placed13

Buys in green, sells in red, by the company’s sector.

Related people

Patrick J. McEnanyDirector and Other role · Director and Other at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Donald A. DenkhausDirector · Director at Catalyst Pharmaceuticals, filing Form 4 there in the last year
David S. TierneyDirector · Director at Catalyst Pharmaceuticals, filing Form 4 there in the last year
Richard J. DalyPresident and CEO · President and CEO at Catalyst Pharmaceuticals, filing Form 4 there in the last year
William T. AndrewsChief Medical Officer · Chief Medical Officer at Catalyst Pharmaceuticals, filing Form 4 there in the last year